Bandopadhyay, Monalisa ; Bulbule, Anuradha ; Butti, Ramesh ; Chakraborty, Goutam ; Ghorpade, Priyanka ; Ghosh, Pompom ; Gorain, Mahadeo ; Kale, Smita ; Kumar, Dhiraj ; Kumar, Santosh ; Totakura, Kumar VS ; Roy, Gaurab ; Sharma, Priyanka ; Shetti, Dattatrya ; Soundararajan, Gowrishankar ; Thorat, Dhanashri ; Tomar, Deepti ; Nalukurthi, Radha ; Raja, Remya ; Mishra, Rosalin ; Yadav, Amit S ; Kundu, Gopal C (2014) Osteopontin as a therapeutic target for cancer Expert Opinion on Therapeutic Targets, 18 (8). pp. 883-895. ISSN 1472-8222
Full text not available from this repository.
Official URL: https://doi.org/10.1517/14728222.2014.925447
Related URL: http://dx.doi.org/10.1517/14728222.2014.925447
Abstract
Cancer is a complex pathological disorder, established as a result of accumulation of genetic and epigenetic changes, which lead to adverse alterations in the cellular phenotype. Tumor progression involves intricate signaling mediated through crosstalk between various growth factors, cytokines and chemokines. Osteopontin (OPN), a chemokine-like protein, is involved in promotion of neoplastic cancer into higher grade malignancies by regulating various facets of tumor progression such as cell proliferation, angiogenesis and metastasis.
| Item Type: | Article |
|---|---|
| Source: | Copyright of this article belongs to Informa plc. |
| Keywords: | Angiogenesis; Biomarkerhy; Poxiaosteopontin; RNAi technology; Stroma; Targeted therapy. |
| ID Code: | 138438 |
| Deposited On: | 22 Aug 2025 12:29 |
| Last Modified: | 22 Aug 2025 12:29 |
Repository Staff Only: item control page
